A 32-year-old woman with a family history of cystic fibrosis (CF) is undergoing genetic screening. Initial mutation analysis by PCR detected the ΔF508 mutation in one allele. To identify the second mutation and confirm compound heterozygosity, which investigation is most appropriate?